Myxobacteria: natural pharmaceutical factories
Juana Diez1, Javier P Martinez, Jordi Mestres
1Molecular Virology Group, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Myxobacteria produce diverse natural products valuable for drug discovery. These microbes may yield human therapeutics by targeting evolutionarily conserved processes shared with their prey.
Area of Science:
- Microbiology
- Natural Products Chemistry
- Drug Discovery
Background:
- Myxobacteria are prolific producers of structurally diverse secondary metabolites.
- These microbes are recognized for their potential in drug discovery due to unique compound properties.
Discussion:
- The study explores why myxobacteria, which prey on bacteria and fungi, produce compounds effective against human diseases.
- A key hypothesis suggests these compounds target evolutionarily conserved cellular processes and structures.
Key Insights:
- Myxobacteria's natural products show significant hits against infectious and non-infectious human diseases.
- The production of beneficial compounds may stem from targeting shared biological pathways.
Outlook:
- Further research into myxobacterial metabolites could uncover novel therapeutic agents.
- Understanding the evolutionary basis of myxobacterial compound synthesis may guide future drug development efforts.
More Related Videos
09:08From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
11:45Fluorescence Live-cell Imaging of the Complete Vegetative Cell Cycle of the Slow-growing Social Bacterium Myxococcus xanthus
Published on: June 20, 2018
Related Concept Videos
Production of Antibiotics
Production of Pharmaceuticals
Microorganisms in Medicine and Therapeutics
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Bacterial Phylum Tenericutes
Bacterial Phylum Actinobacteria
